Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-093441
Filing Date
2025-07-02
Accepted
2025-07-02 19:56:12
Documents
1
Period of Report
2025-02-21

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 4422
  Complete submission text file 0000950170-25-093441.txt   5850
Mailing Address 84 WATERFORD DRIVE MARLBOROUGH MA 01752
Business Address
Iwicki Mark T (Reporting) CIK: 0001415537 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39676 | Film No.: 251103410

Mailing Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801
Business Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801 (302) 295-3800
Inhibikase Therapeutics, Inc. (Issuer) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)